1 Patterson CC, Harjutsalo V, Rosenbauer J, Neu A, Cinek O, Skrivarhaug T, et al. Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25 year period 1989-2013: a multicentre prospective registration study. Diabetologia. 2019;62(3):408–17.
2 Kendall EK, Olaker VR, Kaelber DC, Xu R, Davis PB. Association of SARS-CoV-2 Infection With New-Onset Type 1 Diabetes Among Pediatric Patients From 2020 to 2021. JAMA Network Open. 2022 Sep 23;5(9):e2233014.
3 Rewers M, Bonifacio E, Ewald D, Geno Rasmussen C, Jia X, Pyle L, et al. SARS-CoV-2 Infections and Presymptomatic Type 1 Diabetes Autoimmunity in Children and Adolescents From Colorado, USA, and Bavaria, Germany. JAMA. 2022 Sep 27;328(12):1252–5.
4 Kamrath C, Rosenbauer J, Eckert AJ, Siedler K, Bartelt H, Klose D, et al. Incidence of Type 1 Diabetes in Children and Adolescents During the COVID-19 Pandemic in Germany: Results From the DPV Registry. Diabetes Care. 2022 Jul 26;45(8):1762–71.
5 Qeadan F, Tingey B, Egbert J, Pezzolesi MG, Burge MR, Peterson KA, et al. The associations between COVID-19 diagnosis, type 1 diabetes, and the risk of diabetic ketoacidosis: A nationwide cohort from the US using the Cerner Real-World Data. PLoS One. 2022;17(4):e0266809.
6 Wolfsdorf JI, Glaser N, Agus M, Fritsch M, Hanas R, Rewers A, et al. ISPAD Clinical Practice Consensus Guidelines 2018: diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatr Diabetes. 2018;19(Suppl. 27):155–77.
7 Azova S, Rapaport R, Wolfsdorf J. Brain injury in children with diabetic ketoacidosis: Review of the literature and a proposed pathophysiologic pathway for the development of cerebral edema. Pediatr Diabetes. 2021 Mar;22(2):148–60.
8 Donzeau A, Piffaretti C, Jossens A, Levaillant L, Bouhours-Nouet N, Amsellem-Jager J, et al. Time trend in excess mortality in children with type 1 diabetes from 1987 to 2016 in mainland France. Pediatr Diabetes. 2022 Feb;23(1):38–44.
9 Shalitin S, Fisher S, Yackbovitch-Gavan M, de Vries L, Lazar L, Lebenthal Y, et al. Ketoacidosis at onset of type 1 diabetes is a predictor of long-term glycemic control. Pediatr Diabetes. 2018 Mar;19(2):320–8.
10 Hammersen J, Tittel SR, Warncke K, Fritsch M, Placzek K, Pacaud D, et al. Previous diabetic ketoacidosis as a risk factor for recurrence in a large prospective contemporary pediatric cohort: Results from the DPV initiative. Pediatr Diabetes. 2021 May;22(3):455–62.
11 Cherubini V, Grimsmann JM, Åkesson K, Birkebaek NH, Cinek O, Dovč K, et al. Temporal trends in diabetic ketoacidosis at diagnosis of paediatric type 1 diabetes between 2006 and 2016: results from 13 countries in three continents. 2020 May 7;1–12.
12 Segerer H, Wurm M, Grimsmann JM, Karges B, Neu A, Sindichakis M, et al. Diabetic Ketoacidosis at Manifestation of Type 1 Diabetes in Childhood and Adolescence—Incidence and Risk Factors. Dtsch Arztebl Int. 2021 Jun 4;118(22):367–72.
13 Kamrath C, Mönkemöller K, Biester T, Rohrer TR, Warncke K, Hammersen J, et al. Ketoacidosis in Children and Adolescents With Newly Diagnosed Type 1 Diabetes During the COVID-19 Pandemic in Germany. JAMA. 2020 Aug 25;324(8):801–4.
14 King BR, Howard NJ, Verge CF, Jack MM, Govind N, Jameson K, et al. A diabetes awareness campaign prevents diabetic ketoacidosis in children at their initial presentation with type 1 diabetes. Pediatr Diabetes. 2012 Dec;13(8):647–51.
15 Holder M, Ehehalt S. Significant reduction of ketoacidosis at diabetes onset in children and adolescents with type 1 diabetes-The Stuttgart Diabetes Awareness Campaign, Germany. Pediatr Diabetes. 2020 Nov;21(7):1227–31.
16 Abraham MB, Jones TW, Naranjo D, Karges B, Oduwole A, Tauschmann M, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. 2018 Oct;19 Suppl 27:178–92.
17 Haynes A, Hermann JM, Clapin H, Hofer SE, Karges B, Jones TW, et al. Decreasing trends in mean HbA1c are not associated with increasing rates of severe hypoglycemia in children: a longitudinal analysis of two contemporary population-based pediatric type 1 diabetes registries from Australia and Germany/Austria between 1995 and 2016. Diabetes Care. 2019;42(9):1630–6.
18 Johansen A, Kanijo B, Fredheim S, Olsen B, Hertz B, Lauridsen MH, et al. Prevalence and predictors of severe hypoglycemia in Danish children and adolescents with diabetes. Pediatr Diabetes. 2015 Aug;16(5):354–60.
19 Jaser SS, Jordan LC. Brain Health in Children with Type 1 Diabetes: Risk and Protective Factors. Curr Diab Rep. 2021 Mar 14;21(4):12.
20 Fredheim S, Johansen A, Thorsen SU, Kremke B, Nielsen LB, Olsen BS, et al. Nationwide reduction in the frequency of severe hypoglycemia by half. Acta Diabetol. 2015 Jun;52(3):591–9.
21 Krug AW, Visser SAG, Tsai K, Kandala B, Fancourt C, Thornton B, et al. Clinical Evaluation of MK-2640: An Insulin Analog With Glucose-Responsive Properties. Clin Pharmacol Ther. 2019 Feb;105(2):417–25.
22 Heise T. The future of insulin therapy. Diabetes Res Clin Pract. 2021 May;175:108820.
23 Hoeg-Jensen T. Review: Glucose-sensitive insulin. Mol Metab. 2021 Apr;46:101107.
24 Recent Advances in Enzymatic and Non-Enzymatic Electrochemical Glucose Sensing - PubMed [Internet]. [cited 2022 Oct 8]. Available from: https://pubmed.ncbi.nlm.nih.gov/34300412/
25 Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, et al. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care. 2019 Aug;42(8):1593–603.
26 Shokrekhodaei M, Cistola DP, Roberts RC, Quinones S. Non-Invasive Glucose Monitoring Using Optical Sensor and Machine Learning Techniques for Diabetes Applications. IEEE Access. 2021;9:73029–45.
27 Farrington C. Psychosocial impacts of hybrid closed-loop systems in the management of diabetes: a review. Diabet Med. 2018 Apr;35(4):436–49.
28 Cobry EC, Kanapka LG, Cengiz E, Carria L, Ekhlaspour L, Buckingham BA, et al. Health-Related Quality of Life and Treatment Satisfaction in Parents and Children with Type 1 Diabetes Using Closed-Loop Control. Diabetes Technol Ther. 2021 Jun;23(6):401–9.
29 Karageorgiou V, Papaioannou TG, Bellos I, Alexandraki K, Tentolouris N, Stefanadis C, et al. Effectiveness of artificial pancreas in the non-adult population: a systematic review and network meta-analysis. Metabolism. 2019;90:20–30.
30 Bergenstal RM, Nimri R, Beck RW, Criego A, Laffel L, Schatz D, et al. A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial. Lancet. 2021 Jan 16;397(10270):208–19.
31 Breton MD, Kanapka LG, Beck RW, Ekhlaspour L, Forlenza GP, Cengiz E, et al. A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes. N Engl J Med. 2020 Aug 27;383(9):836–45.
32 Amadou C, Franc S, Benhamou PY, Lablanche S, Huneker E, Charpentier G, et al. Diabeloop DBLG1 Closed-Loop System Enables Patients With Type 1 Diabetes to Significantly Improve Their Glycemic Control in Real-Life Situations Without Serious Adverse Events: 6-Month Follow-up. Diabetes Care. 2021 Mar;44(3):844–6.
33 Cobry EC, Berget C, Messer LH, Forlenza GP. Review of the Omnipod® 5 Automated Glucose Control System Powered by HorizonTM for the treatment of Type 1 diabetes. Ther Deliv. 2020 Aug;11(8):507–19.
34 Berget C, Thomas SE, Messer LH, Thivener K, Slover RH, Wadwa RP, et al. A Clinical Training Program for Hybrid Closed Loop Therapy in a Pediatric Diabetes Clinic. J Diabetes Sci Technol. 2020 Mar;14(2):290–6.
35 Popkin BM, Barquera S, Corvalan C, Hofman KJ, Monteiro C, Ng SW, et al. Towards unified and impactful policies to reduce ultra-processed food consumption and promote healthier eating. Lancet Diabetes Endocrinol. 2021;9(7):462–70.
36 Smart CE, Annan F, Higgins LA, Jelleryd E, Lopez M, Acerini CL. ISPAD Clinical Practice Consensus Guidelines 2018: Nutritional management in children and adolescents with diabetes. Pediatr Diabetes. 2018 Oct;19 Suppl 27:136–54.
37 B D, Vr A, G B, G B, Fm B, R F, et al. 14. Children and Adolescents: Standards of Medical Care in Diabetes-2022. Diabetes care [Internet]. 2022 Jan 1 [cited 2022 Oct 8];45(Suppl 1). Available from: https://pubmed.ncbi.nlm.nih.gov/34964865/
38 Zeevi D, Korem T, Zmora N, Israeli D, Rothschild D, Weinberger A, et al. Personalized Nutrition by Prediction of Glycemic Responses. Cell. 2015 Nov 19;163(5):1079–94.
39 Herron A, Sullivan C, Brouillard E, Steenkamp D. Late to the Party: Importance of Dietary Fat and Protein in the Intensive Management of Type 1 Diabetes. A Case Report. J Endocr Soc. 2017 Aug 1;1(8):1002–5.
40 Kordonouri O, Hartmann R, Remus K, Bläsig S, Sadeghian E, Guntermann C. Die Bolusberechnung anhand von Kohlenhydrat- und Fett-/Protein-Einheiten für kalorienreiche Mahlzeiten bei der Pumpentherapie. Ergebnisse der pädiatrischen Pizza-Salami Studie.
41 Absil H, Baudet L, Robert A, Lysy PA. Benefits of physical activity in children and adolescents with type 1 diabetes: A systematic review. Diabetes Res Clin Pract. 2019 Oct;156:107810.
42 Kennedy A, Nirantharakumar K, Chimen M, Pang TT, Hemming K, Andrews RC, et al. Does exercise improve glycaemic control in type 1 diabetes? A systematic review and meta-analysis. PLoS One. 2013;8(3):e58861.
43 Adolfsson P, Riddell MC, Taplin CE, Davis EA, Fournier PA, Annan F, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Exercise in children and adolescents with diabetes. Pediatr Diabetes. 2018 Oct;19 Suppl 27:205–26.
44 Molveau J, Rabasa-Lhoret R, Taleb N, Heyman E, Myette-Côté É, Suppère C, et al. Minimizing the Risk of Exercise-Induced Glucose Fluctuations in People Living With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion: An Overview of Strategies. Can J Diabetes. 2021 Oct;45(7):666–76.
45 Scott SN, Fontana FY, Cocks M, Morton JP, Jeukendrup A, Dragulin R, et al. Post-exercise recovery for the endurance athlete with type 1 diabetes: a consensus statement. Lancet Diabetes Endocrinol. 2021 May;9(5):304–17.
46 Moniotte S, Owen M, Barrea T, Robert A, Lysy PA. Outcomes of algorithm-based modifications of insulinotherapy during exercise in MDI vs insulin pump-treated children with type 1 diabetes: Results from the TREAD-DIAB study. Pediatr Diabetes. 2017 Dec;18(8):925–33.
47 Riddell MC, Pooni R, Fontana FY, Scott SN. Diabetes Technology and Exercise. Endocrinol Metab Clin North Am. 2020 Mar;49(1):109–25.
48 Delamater AM, de Wit M, McDarby V, Malik JA, Hilliard ME, Northam E, et al. Psychological Care of Children and Adolescents with Type 1 Diabetes. Pediatric Diabetes. 2018 Jul 29;
49 Family interaction in pediatric diabetes - PubMed [Internet]. [cited 2022 Oct 8]. Available from: https://pubmed.ncbi.nlm.nih.gov/21853415/
50 Van Name MA, Hilliard ME, Boyle CT, Miller KM, DeSalvo DJ, Anderson BJ, et al. Nighttime is the worst time: Parental fear of hypoglycemia in young children with type 1 diabetes. Pediatr Diabetes. 2018 Feb;19(1):114–20.
51 Driscoll KA, Raymond J, Naranjo D, Patton SR. Fear of Hypoglycemia in Children and Adolescents and Their Parents with Type 1 Diabetes. Curr Diab Rep. 2016 Aug;16(8):77.
52 Harrison A, Zaremba N, Brown J, Allan J, Konstantara E, Hopkins D, et al. A cognitive behavioural model of the bidirectional relationship between disordered eating and diabetes self care in people with type 1 diabetes mellitus. Diabet Med. 2021 Jul;38(7):e14578.
53 Nip ASY, Reboussin BA, Dabelea D, Bellatorre A, Mayer-Davis EJ, Kahkoska AR, et al. Disordered Eating Behaviors in Youth and Young Adults With Type 1 or Type 2 Diabetes Receiving Insulin Therapy: The SEARCH for Diabetes in Youth Study. Diabetes Care. 2019 May;42(5):859–66.
54 Buchberger B, Huppertz H, Krabbe L, Lux B, Mattivi JT, Siafarikas A. Symptoms of depression and anxiety in youth with type 1 diabetes: A systematic review and meta-analysis. Psychoneuroendocrinology. 2016 Aug;70:70–84.
55 Abraham MB, de Bock M, Smith GJ, Dart J, Fairchild JM, King BR, et al. Effect of a hybrid closed-loop system on glycemic and psychosocial outcomes in children and adolescents with type 1 diabetes: a randomized clinical trial. JAMA Pediatr. 2021;175(12):1227–35.
56 Burckhardt MA, Roberts A, Smith GJ, Abraham MB, Davis EA, Jones TW. The Use of Continuous Glucose Monitoring With Remote Monitoring Improves Psychosocial Measures in Parents of Children With Type 1 Diabetes: A Randomized Crossover Trial. Diabetes Care. 2018 Dec;41(12):2641–3.
57 Barnard KD, Breton MD. Diabetes Technological Revolution: Winners and Losers? J Diabetes Sci Technol. 2018 Nov;12(6):1227–30.
58 Deshpande S, Pinsker JE, Zavitsanou S, Shi D, Tompot R, Church MM, et al. Design and Clinical Evaluation of the Interoperable Artificial Pancreas System (iAPS) Smartphone App: Interoperable Components with Modular Design for Progressive Artificial Pancreas Research and Development. Diabetes Technology & Therapeutics. 2019 Jan;21(1):35–43.
59 Riddell MC, Gallen IW, Smart CE, Taplin CE, Adolfsson P, Lumb AN, et al. Exercise management in type 1 diabetes: a consensus statement. Lancet Diabetes Endocrinol. 2017 May;5(5):377–90.
60 Moser O, Riddell MC, Eckstein ML, Adolfsson P, Rabasa-Lhoret R, van den Boom L, et al. Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA). Pediatr Diabetes. 2020 Dec;21(8):1375–93.
61 Ware J, Allen JM, Boughton CK, Wilinska ME, Hartnell S, Thankamony A, de Beaufort C, Schierloh U, Fröhlich-Reiterer E, Mader JK, Kapellen TM, Rami-Merhar B, Tauschmann M, Nagl K, Hofer SE, Campbell FM, Yong J, Hood KK, Lawton J, Roze S, Sibayan J, Bocchino LE, Kollman C, Hovorka R; KidsAP Consortium. Randomized Trial of Closed-Loop Control in Very Young Children with Type 1 Diabetes. N Engl J Med. 2022;386(3):209-219.